Is neutrophil lymphocyte ratio a prognostic marker of acute ST elevation myocardial infarction?

Authors

  • Sneha Barkur Sadashiva Department of General Medicine, MGMCRI, Pondicherry, India
  • Chenthil K. S. Department of General Medicine, MGMCRI, Pondicherry, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20211485

Keywords:

NLR, STEMI, MACE, TIMI

Abstract

Several inflammatory biomarkers have been implicated in the pathogenesis of acute coronary syndromes. The present study aims to determine the prognostic value of neutrophil lymphocyte ratio (NLR) to predict the immediate outcomes in patients with acute ST elevation myocardial infarction and if any correlation exists between NLR and TIMI risk score. A review of articles published in Pubmed database on the prognostic importance of neutrophil lymphocyte ratio in determining major adverse cardiac events (MACE) such as arrhythmias, cardiogenic shock and in hospital mortality was done. NLR was found to be a reliable prognostic tool to assess the immediate outcome in ST elevation myocardial infarction (STEMI) patients.

References

Hansson GK. Inflammation, atherosclerosis and coronary artery disease. N Engl J Med. 2005;352(16):1685-95.

Hansson GK. Inflammatory mechanisms in atherosclerosis. J Thromb Haemost. 2009;7:328331.

Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JJ. Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol. 2005;46(6):937-54.

Furman MI, Gore JM, Anderson FA, Budaj A, Goodman SG, Avezum A, et al. Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE) Am Heart J. 2004;147(1):42-8.

Barron HV, Cannon CP, Murphy SA, Braunwald E, Gibson CM. Association between white blood cell count, epicardial blood flow, myocardial perfusion, and clinical outcomes in the setting of acute myocardial infarction: a thrombolysis in myocardial infarction 10 sub study. Circulation. 2000;102:2329-34.

Ott I, Neumann FJ, Kenngott S, Gawaz M, Schömig A. Procoagulant inflammatory responses of monocytes after direct balloon angioplasty in acute myocardial infarction. Am J Cardiol. 1998;82(8):938-42.

Lee HY, Kim JH, Kim BO, Yoon Kang J, Ahn HS, Hwang MW, et al. Effect of aspiration thrombectomy on microvascular dysfunction in ST-segment elevation myocardial infarction with an elevated neutrophil count. Korean Circ J. 2011;41(2):68-75.

Rosenfeld ME. Inflammation and atherosclerosis: Direct versus indirect mechanisms. Curr Opin Pharmacol. 2013;13(2):154-60.

Recio-Mayoral A, Rimoldi OE, Camici PG, Kaski JC. Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease. JACC Cardiovasc Imaging. 2013;6(6):660-7.

Yayan J. Emerging families of biomarkers for coronary artery disease: inflammatory mediators. Vasc Health Risk Manag. 2013;9:435-56.

Soehnlein O. Multiple roles for neutrophils in atherosclerosis. Circ Res. 2012;110:875-88.

Keane D, Buis B, Reifart N, Plokker TH, Ernst JM, Mast EG, et al. Clinical and angiographic outcome following implantation of the new less shortening wallstent in aortocoronary vein grafts: introduction of a second generation stent in the clinical arena. J Interv Cardiol. 1994;7(6):557-64.

Tsai I, Wang C, Lu Y, Hung W, Wu C, Lu L, et al. The burden of major adverse cardiac events in patients with coronary artery disease. BMC Cardiovasc Disord. 2017;17:1.

Kacprzak M, Zielinska M. Prognostic value of myeloperoxidase concentration in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Int J Cardiol. 2016;223:452-7.

Poudel I, Tejpal C, Rashid H, Jahan N. Major Adverse Cardiovascular Events: An Inevitable Outcome of ST-elevation myocardial infarction? a literature review .Cureus. 2019;11(7):5280.

Reihani H, SepehriShamloo A, Keshmiri A. Diagnostic value of D dimer in acute myocardial infarction among patients with suspected acute coronary syndrome. Cardiol Res. 2018;9(1):17-21.

Mach F, Schönbeck U, Fabunmi RP, Murphy C, Atkinson E, Bonnefoy JY, et al. T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: Implications for tubule formation. Am J Pathol. 1999;154(1):229-38.

Danenberg HD, Szalai AJ, Swaminathan RV, Peng L, Chen Z, Seifert P, et al. Increased thrombosis after arterial injury in human C-reactive proteintransgenic mice. Circulation. 2003;108(5):512-5.

Morrow DA, de-Lemos JA, Blazing MA, Sabatine MS, Murphy SA. C-reactive protein in cardiovascular disease. JAMA. 2008;294:28662890.

Davies MJ, Woolf N, Rowles PM, Pepper J. Morphology of the endothelium over atherosclerotic plaques in human coronary arteries. Br Heart J. 1988;60(6):459-64.

Wu AH, Smith A, Christenson RH, Murakami MM, Apple FS. Evaluation of a point-of-care assay for cardiac markers for patients suspected of acute myocardial infarction. Clin Chim Acta. 2004;346(2):211-9.

Ghaderi F, Eshraghi A, Shamloo AS, Mousavi S. Assosiation of epicardial and pericardial fat thickness with coronary artery disease. Electron Physician. 2016;8(9):2982-9.

Duncan JL, Dargie JD. The pathogenesis and control of strongyle infection in the horse. J S Afr Vet Assoc. 1975;46(1):81-5.

Rossdale PD, Silver M, Ellis L, Frauenfelder H. Response of the adrenal cortex totetracosactrin (ACTH1-24) in the premature and full-term foal. J Reprod Fertil Suppl. 1982;32:545-53.

Gross WB, Siegel HS. Evaluation of theheterophil/lymphocyte ratio as a measure of stress in chickens. Avian Dis. 1983;27(4):972-9.

Ventafridda V, de Conno F, Saita L,Ripamonti C, Baronzio GF. Leucocyte-lymphocyte ratio as prognostic indicator of survival in cachectic cancer patients. Ann Oncol. 1991;2(3):196.

Goodman DA, Goodman CB, Monk JS. Use of the neutrophil:lymphocyte ratio in the diagnosis of appendicitis. Am Surg. 1995;61(3):257-9.

Burgess LJ, Maritz FJ,Le Roux I, Taljaard JJ. Combined use of pleural adenosine deaminase with lymphocyte/neutrophil ratio increased specificity for the diagnosis of tuberculous pleuritis. Chest. 1996;109(2):414-9.

Hirashima M,Higuchi S, Sakamoto K, Nishiyama T, Okada H. The ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patients with early gastric cancer. J Cancer Res Clin Oncol. 1998;124(6):329-34.

Walsh SR,Cook EJ, GoulderF, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91(3):181-4.

Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy. 2001;102(1):5-14.

Papa A, Emdin M, Passino C, MichelassiC, Battaglia D, Cocci F. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta. 2008;395(1-2):27-31.

Smith RA, Bosonnet L, Ghaneh P, Sutton R, Evans J, Healey P, et al. The platelet-lymphocyte ratio improves the predictive value of serum CA19-9 levels in determining patient selection for staging laparoscopy in suspected periampullary cancer. Surgery. 2008;143(3):658-66.

Azab B, Zaher M, Weiserbs KF, Torbey E, Lacossiere K, Gaddam S, et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol. 2010;106(4):470-6.

Núñez J, Núñez E, Bodí V, Sanchis J, Miñana G, Mainar L, et al. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol. 2008;101(6):747-52.

Nikolsky E, Grines CL, Cox DA, Garcia E, Tcheng JE, Sadeghi M, Mehran R, Lansky AJ.

Turak O, Ozcan F, Isleyen A, Tok D, SokmenE, Buyukkaya E, et al. Usefulness of the neutrophil-to-lymphocyte ratio to predict bare-metal stent restenosis. Am J Cardiol. 2012;110(10):1405-10.

Wang X, ZhangG, Jiang X, Zhu H, Lu Z, Xu L. Neutrophil to lymphocyte ratio in relation to risk of all-cause mortality and cardiovascular events among patients undergoing angiography or cardiac revascularization: a meta-analysis of observational studies. Atherosclerosis. 2014;234(1):206-13.

Azab B, Chainani V, Shah N, McGinn JT. Neutrophil-lymphocyte ratio as a predictor of major adverse cardiac events among diabetic population: a 4-year follow-up study. Angiology. 2013;64(6):456-65.

Sonmez O, Ertas G, Bacaksiz A, Tasal A, Erdoğan E, Asoğlu E, et al. Relation of NLR with presence and complexity of CAD an observational study. Anadolu Kardiyol Derg. 2013;13(7):662-7.

Arbel Y, Finkelstein A, Halkin A, Birati EY, Revivo M, Zuzu M, et al. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis. 2012;225(2):456-60.

Dentali F, Nigro O, Squizzato A, Gianni M, Zuretti F, Grandi AM, et al. Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: A systematic review and meta-analysis of the literature. Int J Cardiol. 2018;266:31-7.

Lou M, Luo P, Tang R, PengY, Yu S, Huang W, et al. Relationship between neutrophil-lymphocyte ratio and insulin resistance in newly diagnosed type 2 diabetes mellitus patients. BMC Endocr Disord. 2015;15:9.

Martinez-Urbistondo D, Beltran A, Beloqui O, Huerta A. The neutrophil-to-lymphocyte ratio as a marker of systemic endothelial dysfunction in asymptomatic subjects. Nefrologia. 2016;36:397-403.

Wang D, Yang JX, Cao DY, Wan XR, Feng FZ, Huang H, et al. Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma. Onco Targets Ther. 2013;6:211-6.

Downloads

Published

2021-04-22

Issue

Section

Review Articles